biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by rustycaton Sep 21, 2017 1:46pm

120 Views

Post# 26726745

RE:RE:RE:RE:RE:RE:Gary Anderson joins Board of Directors, Acquires 5% Interest

roadking,
sorry, it wasn't my intent to flatten your ballon. In fact, I was inspired to research the idea that biologicals were a class of drugs that received faster FDA approval. But, in my search I stumbled on this: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177371
Before reading I suggest you lock up all your guns, knives and alcohol....

Bullboard Posts

Investing with insurance and protection